Orchestrating the gut microbiota–mitochondrial–immune axis in gynecological diseases: mechanisms and dual-targeting therapeutic strategies - Takeaways - MDSpire

Orchestrating the gut microbiota–mitochondrial–immune axis in gynecological diseases: mechanisms and dual-targeting therapeutic strategies

  • By

  • Haixia Tang

  • Yiting Zhang

  • Yanting Wang

  • Ze Zhou

  • Rong Sun

  • Rong Chen

  • Lijuan Yang

  • Mengqiu Shao

  • Jiabao Liao

  • July 1, 2026

  • 0 min

Share

  • 1

    The gut microbiota–mitochondria axis connects metabolism, immunity, and endocrine regulation in gynecological diseases.

  • 2

    Intestinal metabolites like SCFAs and bile acids activate key energy sensing and receptor signaling pathways.

  • 3

    Mitochondrial dysfunction can amplify innate immune responses and alter gut microbiota composition.

  • 4

    Research indicates dysbiosis in PCOS patients exacerbates mitochondrial oxidative stress and insulin resistance.

  • 5

    The review proposes a dual-targeted treatment approach focusing on microbiota and mitochondrial interventions.

Original Source(s)

Orchestrating the gut microbiota–mitochondrial–immune axis in gynecological diseases: mechanisms and dual-targeting therapeutic strategies

  • by Haixia Tang, Yiting Zhang, Yanting Wang, Ze Zhou, Rong Sun, Rong Chen, Lijuan Yang, Mengqiu Shao, Jiabao Liao

  • July 1, 2026

Related Content

Hydrogen sulfide donor sodium hydrosulfide modulates ovarian steroidogenesis and follicular integrity in a DHEA-induced rat model of polycystic ovary syndrome

Adjunctive berberine improves hormonal, metabolic, and inflammatory profiles in women with polycystic ovary syndrome: a retrospective case–control study

GLP-1 Drugs Tied to Lower Addiction Risk

In a target-trial emulation of more than 600,000 veterans, GLP-1 RA initiators saw fewer new substance use disorders—and patients with existing SUDs had fewer overdoses, hospitalizations, and deaths.